中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation

文献类型:期刊论文

作者Wenlan Chen; Chengfeng Xia; Li Cai; Peng George Wanga
刊名BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
出版日期2010-07-01
卷号20期号:13页码:3859-3862
关键词Nkt Cells Glycolipid Ceramide
ISSN号0960-894X
DOI10.1016/j.bmcl.2010.05.045
文献子类Article
英文摘要Glycolipids are potential antigens for iNKT cells recognition and demonstrate important roles in both innate and adaptive immunity. However, the difficulties in the preparation of pure configuration defined glycolipids limit the exploration of their different profiles in activating iNKT cells. We report here a concise and stereospecific preparation of novel galactosylceramide analogues by oxime ligation. This strategy would provide an efficient way to generate varied glycolipid analogues with either synthetic or natural carbohydrates for biological evaluations. (c) 2010 Elsevier Ltd. All rights reserved.
学科主题Chemistry, Medicinal ; Chemistry, Organic
WOS关键词KILLER T-CELLS ; ALPHA-GALACTOSYLCERAMIDE ; NKT CELLS ; ISOGLOBOTRIHEXOSYLCERAMIDE ; AGONIST ; ACTIVATION ; RESPONSES ; CERAMIDE ; KRN7000 ; LIGAND
WOS研究方向Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000278644700005
资助机构Ohio State University ; NIH [R21AI083513]
公开日期2012-03-21
源URL[http://ir.kib.ac.cn:8080/handle/151853/4142]  
专题昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Wenlan Chen,Chengfeng Xia,Li Cai,et al. Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2010,20(13):3859-3862.
APA Wenlan Chen,Chengfeng Xia,Li Cai,&Peng George Wanga.(2010).Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,20(13),3859-3862.
MLA Wenlan Chen,et al."Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 20.13(2010):3859-3862.

入库方式: OAI收割

来源:昆明植物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。